Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2010 - 2018)
Ironwood Pharmaceuticals (IRWD) reported Amortizatization of Intangibles of $8000.0 for Q4 2018, down 92.45% on a YoY basis from $106000.0 in Q4 2017, and down 57.89% sequentially from $19000.0 in Q3 2018.
Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2010 - 2018) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 9 years of Amortizatization of Intangibles data on file, last reported at $8000.0 in Q4 2018.
- For the quarter ending Q4 2018, Amortizatization of Intangibles fell 92.45% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2018 stood at $165000.0 (up 120.0% YoY), and the FY2018 full-year result was $165000.0, up 120.0% from the prior year.
- Amortizatization of Intangibles eased to $8000.0 in Q4 2018, from $19000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $118000.0 in Q1 2018 to a low of -$722000.0 in Q3 2015.
- A 5-year average of -$133263.2 and a median of -$106000.0 in 2016 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles tumbled 111.18% in 2016 and soared 433.33% in 2018, its largest moves.
- Tracing IRWD's Amortizatization of Intangibles over 5 years: stood at -$261000.0 in 2014, then slumped by 176.63% to -$722000.0 in 2015, then surged by 85.32% to -$106000.0 in 2016, then surged by 200.0% to $106000.0 in 2017, then plunged by 92.45% to $8000.0 in 2018.
- Business Quant data shows IRWD's Amortizatization of Intangibles at $8000.0 in Q4 2018, $19000.0 in Q3 2018, and $20000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Ironwood Pharmaceuticals | 644.00 Mn | 423.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 8,000.00 |
| Dec 31, 2018 | 8,000.00 |
| Sep 30, 2018 | 19,000.00 |
| Sep 30, 2018 | 19,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 118,000.00 |
| Mar 31, 2018 | 118,000.00 |
| Dec 31, 2017 | 106,000.00 |
| Dec 31, 2017 | 106,000.00 |
| Sep 30, 2017 | 80,000.00 |
| Sep 30, 2017 | 80,000.00 |
| Jun 30, 2017 | -6,000.00 |
| Jun 30, 2017 | -6,000.00 |
| Mar 31, 2017 | -105,000.00 |
| Mar 31, 2017 | -105,000.00 |
| Dec 31, 2016 | -106,000.00 |
| Dec 31, 2016 | -106,000.00 |
| Sep 30, 2016 | -104,000.00 |
| Sep 30, 2016 | -104,000.00 |